Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review

Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review

The BNT162b2 Pfizer/BioNTech vaccine was the first emergency approved vaccine during the COVID-19 pandemic. The aim of this systematic review was to examine the variations in the humoral immune response induced by the administration of the BNT162b2 vaccine in patients with previous SARS-CoV-2 infect...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Karen Cortés-Sarabia, Mayralina Gutiérrez-Torres, Escarlet Maleny Mendoza-Renteria, Marco Antonio Leyva-Vázquez, Amalia Vences-Velázquez, Daniel Hernández-Sotelo, Fredy Omar Beltrán-Anaya, Oscar Del Moral-Hernández, Berenice Illades-Aguiar
Formaat: Artikel
Taal:English
Gepubliceerd in: MDPI AG 2022-06-01
Reeks:Vaccines
Onderwerpen:
BNT162b2
vaccine
SARS-CoV-2
COVID-19
humoral response
comorbidities
Online toegang:https://www.mdpi.com/2076-393X/10/6/909

Internet

https://www.mdpi.com/2076-393X/10/6/909

Gelijkaardige items